About this trial
The present study will examine whether women at high risk for developing hypertension, i.e., post-menopausal status, at least mild psychological distress, and mildly elevated blood pressure, show improvements in these risk factors after a 12-week Transcendental Meditation (TM) intervention compared to Women's Health Education (WHE). Positive findings will provide initial evidence of using nonpharmacological methods, such as TM, to prevent hypertension in postmenopausal women.
Eligibility criteria
Qualifiers
≥130 systolic blood pressure (SBP) ≤160 and/or 84 ≥ diastolic blood pressure (DBP) ≤100.
Perceived stress scale (PSS-4) > 5
Able to give informed consent.
Understand study procedures and comply with them for the length of the study.
Disqualifiers
Currently in a meditation program.
Meditates more than once per week
Recent stroke or cerebral neurologic impairment.
Current uses of mood stabilizers or antipsychotics.
Trial design
Treatments tested in this trial
- Transcendental Meditation (TM)
- Women's Health Education (WHE)